Home/Filings/4/0001209191-16-090356
4//SEC Filing

Cerulean Pharma Inc. 4

Accession 0001209191-16-090356

$DARECIK 0001401914operating

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:13 PM ET

Size

5.5 KB

Accession

0001209191-16-090356

Insider Transaction Report

Form 4
Period: 2016-01-05
GUIFFRE CHRISTOPHERD T
Chief Operating Officer
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2016-01-05+137,000137,000 total
    Exercise: $3.04Exp: 2026-01-04Common Stock (137,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 5, 2016. The option vests in 48 equal monthly installments over the four year period following the date of grant.

Issuer

Cerulean Pharma Inc.

CIK 0001401914

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001401914

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:13 PM ET
Size
5.5 KB